Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and... see more

TSX:WELL - Post Discussion

View:
Post by retiredcf on Jan 22, 2024 10:07am

CIBC

This is the only thing I can find this morning so perhaps a CIBC fund is closing out a position. Unsure which other two companies he is referring to but as can be seen, this analyst is nowhere close to market consensus. GLTA

CIBC’s Scott Fletcher downgraded Well Health Technologies Corp. (WELL-T) to “neutral” from “outperformer” with a $4.75 target, down from $5.50 and below the $8.08 average.

“WELL faced margin headwinds across its business in 2023 and we expect margins to remain pressured into 2024, slowing EBITDA growth,” he said. “We are also adjusting our valuation to better account for shareholders’ portion of WELL’s EBITDA, leading to a reduction in our price target from $5.50 to $4.75. We prefer a wait-and-see approach as WELL works to implement cost savings initiatives and integrates recent acquisitions. In addition to the WELL downgrade and price target change, we are rolling our financial models forward to 2025 for all three companies and updating our price target calculations.”

Comment by sorrenson on Jan 22, 2024 11:26am
The man is an idiot . But dont believe me , Believe the CIBC  Win-loss rate   3 out of 15 successful ratings    20% Average return Average return per rating: -11.0% A monkey throwng darts can do better
Comment by NLMoose on Jan 22, 2024 12:17pm
CIBC should be ashamed of themselves for thinking negatively about a stock with great potential and value like Well Health. Besides, CIBC should have no right to make judgements about a stock. That should be up to a major bank like TD Canada Trust or RBC, not a jobber like CIBC.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities